1 d analysis software version 4 6 7 (Bio-Rad)
99
Structured Review
Bio-Rad
1 d analysis software version 4 6 7
1 D Analysis Software Version 4 6 7, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 216 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+d+analysis+version+4+6+1+software/PrimePCR+Analysis+Software/pmc12240175-147-9-14
Average 99 stars, based on 216 article reviews
1 D Analysis Software Version 4 6 7, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 99/100, based on 216 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/1+d+analysis+version+4+6+1+software/PrimePCR+Analysis+Software/pmc12240175-147-9-14
Average 99 stars, based on 216 article reviews
1 d analysis software version 4 6 7 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Western Blot:Article Title: Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease. Article Snippet: Metformin is a medication that is widely prescribed for the management of type 2 diabetes.. In addition to its antidiabetic uses, metformin has been proposed as a therapeutically effective drug candidate in various central nervous system disorders, including Parkinson’s disease (PD).. PD is characterized by severe movement defects and is commonly treated with the dopamine (DA) precursor 3,4-dihydroxyphenyl-lalanine (L-DOPA). Article Title: Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Depression-like behaviors induced by defective PTPRT activity through dysregulated synaptic functions and neurogenesis. Article Snippet: Blots were incubated with primary and secondary antibodies followed by visualization using an Enhanced Chemiluminescence kit (Atto Corp., Japan). .. Immunoblot images were quantified using Quantity One Article Title: Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder Article Snippet: Blots were incubated with primary and secondary antibodies followed by visualization using an Enhanced Chemiluminescence kit (Atto Corp., Japan). .. Immunoblot images were quantified using Quantity One Software:Article Title: Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease. Article Snippet: Metformin is a medication that is widely prescribed for the management of type 2 diabetes.. In addition to its antidiabetic uses, metformin has been proposed as a therapeutically effective drug candidate in various central nervous system disorders, including Parkinson’s disease (PD).. PD is characterized by severe movement defects and is commonly treated with the dopamine (DA) precursor 3,4-dihydroxyphenyl-lalanine (L-DOPA). Article Title: Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Depression-like behaviors induced by defective PTPRT activity through dysregulated synaptic functions and neurogenesis. Article Snippet: Blots were incubated with primary and secondary antibodies followed by visualization using an Enhanced Chemiluminescence kit (Atto Corp., Japan). .. Immunoblot images were quantified using Quantity One Article Title: Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson's disease. Article Snippet: 1 Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125, Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea 2 Core Research Facility & Analysis Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125, Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea 3 College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 28160, Republic of Korea 4 Department of Biomaterials Science, College of Natural Resources and Life Science/Life and Industry Convergence Research Institute, Pusan National University, Miryang 50463, Korea 5 KRIBB School, University of Science and Technology, Daejeon 34141, Republic of Korea Abstract L-dopa-induced dyskinesia (LID) is an incapacitating complication of long-term administration of L-dopa therapy that commonly affects patients with Parkinson’s disease (PD) due to the widespread use of the causative drug.. Herein, we investigated the therapeutic potential of sitagliptin, a drug used to treat type 2 diabetes mellitus, to treat LID.. 6-hydroxydopamine (6-OHDA) was unilaterally injected into the left side of the substantia nigra pas compacta to induce a mouse model of PD. Article Title: Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder Article Snippet: Blots were incubated with primary and secondary antibodies followed by visualization using an Enhanced Chemiluminescence kit (Atto Corp., Japan). .. Immunoblot images were quantified using Quantity One |